Resveratrol and inflammatory bowel disease: the evidence so far - Nunes, Sandra; Danesi, Francesca; Del Rio, Daniele; Silva, Paula (Nutrition research reviews, 2018)
Keywords: Animal models; anti-inflammatory activity; Anti-inflammatory agents; Berries; Bioactive compounds; Biosynthesis; Breast cancer; Cancer therapies; Clinical trials; Colorectal cancer; Crohn's disease; Cytokines; Drug delivery; Formulations; Fruits; grape juice; Grapes; Immunity; In vivo methods and tests; in vivo studies; Inflammation; Inflammatory bowel disease; Inflammatory bowel diseases; Inflammatory diseases; Intestinal absorption; intestinal mucosa; Intestine; Medical research; Metabolism; Metabolites; Monoclonal antibodies; Mucosa; Phenols; Polygonum cuspidatum; polyphenols; red wines; Resveratrol; small fruits; Small intestine; Studies; therapeutics; Vitaceae; Wine; Wines; Inflammatory bowel disease; Inflammation; Stilbenes; Grapes; Resveratrol; (Poly)phenols; DSS dextran sulfate sodium; BCRP breast cancer resistance protein; MRP multidrug resistance protein; SphK1 sphingosine kinase 1; 6-trinitrobenzenesulfonic acid; Th17 T helper 17 cells; COX-2 cyclo-oxygenase-2; STAT signal transducer and activator of transcription; 4; miRNA microRNA; UC ulcerative colitis; TNBS 2; IBD inflammatory bowel disease